Menu Back toLS36: Patient Engagement - Recent Practices and Future Enhancement in Japan
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
18th DIA Japan Annual Meeting 2021
All prices are exclusive of 10% Japanese consumption tax
LS36: Patient Engagement - Recent Practices and Future Enhancement in Japan
- Patient Advocacy Relations Medical Advisor
- Nippon Boehringer Ingelheim Co., Ltd., Japan
- Japan-Asia Clinical Development 2
- Astellas Pharma Inc, Japan
- Associate Director, Study Operation
- MSD K.K., Japan